Continued depression of maximal oxygen consumption and mitochondrial proteomic expression despite successful coronary artery bypass grafting in a swine model of hibernation  by Kelly, Rosemary F. et al.
Kelly et al Evolving Technology/Basic ScienceContinued depression of maximal oxygen consumption and
mitochondrial proteomic expression despite successful coronary
artery bypass grafting in a swine model of hibernationRosemary F. Kelly, MD,a,d Jesus A. Cabrera, MD, PhD,a,d Elizabeth A. Ziemba, MD,a Melanie Crampton,b

















doi:10.1Objective: Clinical studies indicate incomplete functional recovery of hibernating myocardium after coronary
artery bypass grafting. We hypothesized that persistent contractile abnormalities after coronary artery bypass
grafting are associated with decreased mitochondrial proteins involving electron transport chain that might limit
maximal oxygen consumption.
Methods: Seven pigs with hibernating myocardium underwent off-pump revascularization with left internal
thoracic artery to mid left anterior descending artery. At 4 weeks, left internal thoracic artery anastomosis
was patent by multidetector computed tomography. Regional function (transthoracic echocardiography) and
blood flow (microspheres) were assessed at rest and during high-dose dobutamine (40 mg/[kg $ min]). Expres-
sion of electron transport chain proteins was analyzed with isobaric tags for relative and absolute quantification.
Results:After revascularization, multidetector computed tomography confirmed severe left anterior descending
stenosis and patent left internal thoracic artery graft. Regional function and blood flow normalized at rest; how-
ever, function in left anterior descending distribution remained depressed relative to remote regions, and myo-
cardial blood flow in that region did not increase normally when challenged with high-work state. Concomitant
with reduced maximal blood flow response in left anterior descending region was more than 40% reduction in
electron transport chain proteins essential to adenosine triphosphate production.
Conclusions:Despite successful revascularization of hibernatingmyocardium, regional function and blood flow
remained depressed during catecholamine stress. Electron transport chain proteins known to be downregulated
during adaptive process within hibernating myocardium did not normalize after revascularization. These data
demonstrate a potential bioenergetic cause of persistent dysfunction and heart failure within successfully revas-
cularized hibernating myocardium. (J Thorac Cardiovasc Surg 2011;141:261-8)Hibernating myocardium is a clinical entity that is mani-
fested as viable but persistently dysfunctional myocardium
in response to repetitive myocardial ischemia and is charac-
terized by reduced regional blood flow without evidence of
necrosis.1,2 Experimental studies indicate that several
adaptations occur in response to chronic hypoperfusion,
including remodeling of resistance vessels,3 increased glu-
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Sproteins,6,7 and apoptosis.8 These responses to chronic
ischemia may be a coordinated response to downregulate
myocardial oxygen expenditure with the reduced oxygen
availability and thus ensure myocyte survival. Clinically,
revascularization of hibernating myocardium results in vari-
able degrees of contractile recovery, and this heterogeneous
response may reflect the inability of the myocardium to
reverse these pleomorphic adaptations in full.
Since the seminal observation byMurray and colleagues9
of ischemic myocardial preconditioning in the anesthetized
canine model, mitochondria have been identified as being
central to the understanding of myocardial protection.10
The chronically ischemic mitochondria within the myocyte
must adapt to hypoxia resulting from decreased blood flow,
with a balanced reduction in energy and reactive oxygen
species production to preserve myocardium.11 As we have
shown, adaptations to hibernation are multifactorial and in-
volve alterations in the bioenergetics and proteomics of the
mitochondria that allow the tissue to maintain viability but
at reduced rate of energy production.12 An inability to sup-
port electron flow through the electron transport chain
(ETC) may lead to inefficient oxygen consumption during
high work states, and a downregulation of ETC protonrdiovascular Surgery c Volume 141, Number 1 261
Abbreviations and Acronyms
ETC ¼ electron transport chain
iTRAQ ¼ isobaric tags for relative and absolute
quantification
LAD ¼ left anterior descending coronary artery
LITA ¼ left internal thoracic artery
MDCT ¼ multidetector computed tomography
MS ¼ mass spectrometry
RCI ¼ respiratory control index
TTE ¼ transthoracic echocardiography




Sgradient could therefore result in a negative effect on max-
imal oxygen expenditure and subsequently on myocardial
contraction. We believe that hibernating myocardium is
a coordinated proteomic response to persistent ischemic
stresses that result in preserved viability at the expense of
maximal energy production.11 The reversibility of these ad-
aptations after revascularization has never been tested in
suitable animal models. On the basis of the variable recov-
eries of hibernating myocardium in clinical studies, we pos-
tulated that mitochondrial proteomic adaptations, which
limit oxidative injury and apoptosis at the expense of
maximal oxygen consumption and functional recovery,
may persist despite revascularization.
In a swine model of hibernating myocardium, we hypoth-
esized that persistent myocardial wall motion abnormality
in revascularized myocardium by off-pump coronary artery
bypass graft (CABG) is associated with persistently de-
pressed expression of key mitochondrial proteins involved
with the ETC.MATERIALS AND METHODS
Animal Model
All animal studies were approved by the institutional animal care and
use committee of the Minneapolis VA Medical Center and conform to
current National Institutes of Health (Guide for the Care and Use of
Laboratory Animals, www.nap.edu/catalog/5140.html) and American
Physiological Society guidelines for the use and care of laboratory animals.
Operative Technique
To create a model that reflects the clinical situation, we used a well-
established swine model of chronic myocardial ischemia.4,12 Two
survival operations and a terminal operation were performed in 7
animals during a 16-week time course. The first operation created
hibernating myocardium with the placement of a left anterior descending
artery (LAD) occluder at time 0, the second operation surgically
revascularized the myocardium with left internal thoracic artery (LITA)
to LAD at 12 weeks, and finally the terminal procedure occurred 4
weeks after the bypass operation at 16 weeks.
Chronic hibernation model (8- to 10-kg pigs). Animals
were sedated with tiletamine hydrochloride and zolazepam (Telazol, 4 mg/
kg intramuscularly) and xylazine (2 mg/kg intramuscularly), intubated,
and anesthetized with isoflurane (2%). Through a left thoracotomy ap-
proach, the chest and pericardium were opened in a sterile fashion. The262 The Journal of Thoracic and Cardiovascular SurgLADwas dissected free, and a plastic c-shaped ringwith an internal diameter
of 2 mm encircled the LAD proximal to the first diagonal without occluding
the vessel and was secured with sutures. The thoracotomy incision was
closed in layers. The animal recovered for 12 weeks. We have previously
shown that this vascular constrictor does create hibernating myocardium
with a reduction in regional blood flow in the LAD region with time and
loss ofwall thickening in the anteriorwall function12weeks after instrumen-
tation.4,12 To confirm hibernating myocardium, we documented proximal
LAD stenosis by multidetector computed tomography (MDCT) and wall
motion abnormality by transthoracic echocardiography (TTE) before the
second operation. At 12 weeks, animals underwent the second survival
operation, which was revascularization of the hibernating myocardium.
Revascularization model (50- to 60-kg pigs). Animals were
again sedated, intubated, and anesthetized as noted previously. Coronary
artery revascularization was performed through a midline sternotomy
with the LITA dissected free from the chest wall. Lidocaine (1 mg/kg)
was administered before opening the pericardium. The LAD distal to the
site of c-ring occlusion was then exposed. The animal was heparinized
(100 unit/kg). With an off-pump technique, the LAD was stabilized with
a Titan Stabilizer (Estech, San Ramon, Calif). LAD perfusion was main-
tained with a Flo-thru intraluminal shunt (Synovis Surgical Innovations,
St Paul, Minn). A LITA anastomosis to the LAD was performed just be-
yond the occluder with 8-0 Prolene suture (Ethicon, Inc, Somerville, NJ).
On completion of the anastomosis, the shunt and LITA occluder were re-
moved. Protamine was given to reverse the heparin, and the chest was
closed in layers. A second MDCT and TTE were done before the terminal
study at 16 weeks.
Terminal procedure (70- to 80-kg pigs). Four weeks after re-
vascularization, a terminal study was performed. Animals were sedated, in-
tubated, anesthetized, and monitored. Femoral and carotid arterial
monitoring lines were placed to monitor blood pressure, obtain blood sam-
ples, and infuse intraventricular coloredmicrospheres. Fluorescently labeled
colored microspheres were injected into the left ventricle before and after
a 5-minute infusion of dobutamine (40 mg/[kg $min]) to determine regional
blood flows. A resternotomy was performed to excise the heart, and tissue
samples were obtained for blood flow, proteomic, and histologic analyses.
Echocardiographic Analysis
Two-dimensional TTE measured regional myocardial function in the
LAD and circumflex regions of the swine heart. The circumflex region (re-
mote) was used as the control, with measurements made at standardized lo-
cations to allow comparisons between animals. TTE with and without
dobutamine infusion was performed with a Vivid 7 Ultrasound machine
(GE Healthcare, New York, NY) during deep sedation without intubation.
Heart rate, heart rhythm, and oxygenation were monitored during the pro-
cedure. Wall thickening was measured at the right parasternal short-axis
view in the posterior (circumflex) and anterior (LAD) walls. Wall thicken-
ing was computed as the difference between end-systolic and end-diastolic
wall thicknesses and expressed as a percentage of end-diastolic thickness.
MDCTAnalysis
MDCTwas used to document LAD stenosis and confirm LITA graft pa-
tency. MDCT scanning of the hibernating and revascularized swine models
was performed with the Brilliance 40 MDCT scanner (Phillips Medical
Systems, Cleveland, Ohio) during deep sedation with Telazol without des-
ignated breath hold or b-blockade. Electrocardiographically gated image
acquisition was used to reconstruct images retrospectively. A volume of
150 mL of contrast media was injected intravenously at a rate of 4 mL/s.
Scanning was triggered automatically when contrast enhancement within
the descending aorta reached a threshold level of 150 Hounsfield units.
At least 10 phases were reconstructed for each study, and coronary analysis
was done at either 75% phase or end-systolic phase. Image analysis was
done with a dedicated workstation (Philips Extended Brilliance Work-
space; Phillips Medical Systems).ery c January 2011





Myocardial blood flow was quantified with fluorescently labeled 15-mm
diameter microspheres injected into the left ventricle at rest and after a 5-
minute dobutamine (40 mg/[kg $min]) infusion at the terminal study. Forty
thousand fluorescently labeled microspheres (Triton Technology Inc, San
Diego, Calif) per kilogram were injected for each analysis. At the terminal
study, the heart was serially sectioned, and samples of fresh tissuewere rap-
idly excised from subendocardial and subepicardial LAD and remote terri-
tories for regional perfusion analysis. Approximately 1 g of tissue was
digested with 4-mol/L potassium hydroxide with 1% polysorbate 80 for
72 hours. The digested material was filtered through 10-mm Isopore mem-
brane filter (Millipore Corporation, Billerica, Mass) to retain the micro-
sphere sediments on the filter. The filters were washed in 3 mL
diethylene glycol monoethyl ether acetate, which dissolves the micro-
spheres and releases the fluorochrome. The fluorescent signal was then
measured in a PerkinElmer LS-55 Luminescence Spectrometer (Perki-
nElmer Inc, Waltham, Mass). The fluorescent signal was normalized to
the tissue weight, and differences between samples were analyzed.
Histologic Analysis
Tissue samples were fixed with 4% paraformaldehyde and processed as
paraffin-embedded sections. For histochemical examination, sections were
stained with hematoxylin-eosin and Masson trichrome. Triphenyl tetrazo-
lium chloride stain was used to confirm viability of the myocardium.
Mitochondrial Isolation
Fresh tissue was rapidly excised from subendocardial regions of the
LAD and remote territories. As previously described, myocardial tissue
was placed in ice cold mitochondrial isolation buffer (pH 7.15) containing
50-mmol/L sucrose, 200-mmol/L mannitol, 1-mmol/L ethylene glycol
tetraacetic acid. 5-mmol/L potassium hypophosphite, 5-mmol/L 3-(N-
morpholino) propanesulfonic acid, nagarse (2 mg/mL) and 0.1% fatty
acid–free bovine serum albumin. Myocardium was minced, and a 5%
homogenate was made.13 The supernatant was centrifuged twice, each at
8000g for 10 minutes. The mitochondria were collected, and the protein
concentration was determined. In general, the mitochondrial preparations
contained approximately 5 mg protein/mL, and the citrate synthase activity
amounted to 2.4 U/mg.
Mitochondrial Respiration
Mitochondria were suspended in mitochondrial respiration buffer com-
posed of 110-mmol/L sucrose, 0.5-mmol/L ethylene glycol tetraacetic
acid, 3-mmol/L magnesium chloride, 70-mmol/L potassium chloride,
10-mmol/L potassium dihydrogen phosphate, 20-mmol/L taurine,
20-mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and
0.1% fatty acid–free bovine serum albumin. They were placed into the res-
piration chamber equipped with a Clark electrode to measure oxygen con-
centrations at 25C. Once a steady state had been achieved, state 2
respiration was assessed by determining the rate constant for oxygen con-
sumption in the presence of complex I (10-mmol/L glutamate and 5-mmol/
L malate) and complex II (10-mmol/L succinate) substrates. Once the ox-
ygen curvewas stable, 5-mmol/L adenosine diphosphatewas given, and the
rate constant for oxygen consumption was determined for calculation of
state 3 conditions. The respiratory control index (RCI) was defined by
the ratio of state 3 to state 2.
Isobaric Tags for Relative and Absolute
Quantification of Mitochondrial Proteins
Identification and relative quantification of inner matrix proteins from
mitochondria that have been isolated from the swine was performed with
isobaric tags for relative and absolute quantification (iTRAQ) reagents
(Applied Biosystems Inc, Foster City, Calif) in conjunction with liquid
chromatography and tandemmass spectrometry (MS). The iTRAQ isobaricThe Journal of Thoracic and Careagents labeled all primary amines to yield labeled peptides that were
identical in mass and were also identical in single MS mode. In tandem
MS mode, however, they produced strong, diagnostic, low-mass signature
ions in each of the 8 different samples, which allowed quantification from
all 8 samples. We compared the protein concentrations from mitochondria
of the LAD region for each of the revascularized animals with those from
a size- and sex-matched control animal that had not undergone any surgical
procedures. To extract mitochondrial proteins from individual samples,
80 mg of the mitochondrial protein isolates were centrifuged and the pellet
was rehydrated in 0.5-mol/L triethylammonium bicarbonate buffer (pH
8.5), reduced, alkylated, trypsin digested independently in parallel, and la-
beled with iTRAQ reagents to each of the samples. After labeling of the
peptides, all samples were pooled and dried in vacuum before liquid chro-
matography and tandem MS. To reduce the complexity of the tryptic pep-
tides, peptides were separated by a strong cation exchange into 16
fractions. The peptides from each fraction were separated by reverse-
phase high-performance liquid chromatography and then introduced online
into a mass spectrometer.14 The capillary high-performance liquid chroma-
tography system was interfaced with QSTAR Pulsar i quadrupole mass
spectrometer (Applied Biosystems) with a nanoelectrospray ionization
source.15 Protein identification and relative quantification were carried
out with ProteinPilot version 2 software (Applied Biosystems). For relative
quantification, ProteinPilot calculated the iTRAQ ratio for each reagent
pair and determined an average iTRAQ ratio for each protein.14 This rela-
tive quantification was based on the ratio of the mitochondrial protein ex-
pression from the LAD region in each revascularized animal versus the
mitochondrial protein expression from the LAD region of a control animal.
This ratio indicated whether a protein was upregulated or downregulated.
Statistical Analysis
Blood flow data were analyzed by assessing the quantity of fluorescence
trapped in the LAD tissue at the time of injection of the microspheres rel-
ative to that in remote tissue. Means and SEs were calculated for each
group. TTE and RCI data were expressed as mean  SE. Differences be-
tween LAD and remote regions in blood flow, TTE, and RCI analyses
were tested with the Student paired t test. The iTRAQ analysis used a stan-
dard protocol to compare the ratio of protein expression of isolated
mitochondria between normal and revascularized myocardium. The ex-
pression of proteins was denoted as mean SE. A 1-sample t test analysis
with a hypothesized mean of 1 was performed with the statistical software
package StatView version 5.0.1 (SAS Institute Inc, Cary, NC).
RESULTS
We performed 7 hibernation surgical procedures fol-
lowed by revascularization surgery in a swine model. All
animals that underwent the revascularization operation sur-
vived to the terminal procedure performed 4 weeks after re-
vascularization. There were no infections of any surgical
site, and there were no animal losses, sternal complication,
or myocardial infarctions during or after the revasculariza-
tion surgery. Each animal served as its own control, with the
LAD region compared with the circumflex artery (remote)
region.
At the time of the terminal study, all animals had a patent
LITA to LAD anastomosis. The anastomosis was confirmed
to be patent with a 1.5-mm probe. The occluder site was less
than 1.0 mm probe diameter, and the LAD just distal to the
occluder measured at least 2.5 mm in diameter in all ani-
mals. Triphenyl tetrazolium chloride staining of the myo-
cardium beyond the LITA to LAD anastomosis confirmed
viability in all 7 animals.rdiovascular Surgery c Volume 141, Number 1 263
FIGURE 1. A, Transthoracic echocardiography performed at 12 weeks
confirmed hibernation with reduced function in left anterior descending
coronary artery (LAD) region relative to remote region at baseline
(n ¼ 6). Asterisk indicates P< .05. B, Transthoracic echocardiography
(TTE) performed 4 weeks after revascularization of hibernating myocar-
dium compared percentage wall thickness change of left anterior descend-
ing coronary artery (LAD) territory (hibernation) with remote (control)
territory. Measurements were taken from images obtained at baseline and
with dobutamine infusion of 40 mg/(kg $ min) for 5 minutes (n ¼ 7).
Asterisk indicates P<.05.




SMyocardial function was assessed by 2-dimensional TTE
done under sedation to assess regional wall abnormalities
compared to remote regions. We used a method similar toFIGURE 2. A. Multidetector computed tomographic image of left anterior desc
tion surgery (CABG).B,Multidetector computed tomography illustrates proxima
patent left internal thoracic artery (LIMA) to left anterior descending coronary a
264 The Journal of Thoracic and Cardiovascular Surgour previous experiencewith hibernating myocardium stud-
ies.4 Twelve weeks after LAD occluder placement, animals
showed evidence of hibernating myocardium, with reduced
wall thickening at rest in the LAD territory (Figure 1, A). At
4 weeks after revascularization, a repeat TTE was per-
formed. This TTE was done at rest and with a dobutamine
infusion (40 mg/[kg $min]). We found that after revascular-
ization, the baseline function of the LAD territory returned
to normal function. During dobutamine infusion, however,
the revascularized myocardium showed incomplete recov-
ery of myocardial function relative to remote myocardium
(Figure 1, B).
After TTE studies, cardiac-gated MDCT studies were
performed at 12 weeks to assess coronary anatomy and
occluder stenosis and at 16 weeks to confirm LITA to
LAD graft patency. At 12 weeks, all animals had confirmed
proximal LAD stenosis greater than 70% at the site of the
occluder (Figure 2, A). The animals underwent revascular-
ization with LITA to LAD, and at 16 weeks all 7 animals
had patent LITA to LAD graft anastomoses confirmed by
MDCT (Figure 2, B). Graft patency finding was proved ac-
curate in all animals at necropsy by direct instrumentation
with 1.5-mm probe.
At the terminal procedure, blood flow had returned to
normal at rest in the revascularized hibernating myocar-
dium relative to the remote region after revascularization
(Figure 3). Blood flow during dobutamine infusion, how-
ever, was reduced by 30% relative to normal. This region
correlated with the area with persistently depressedmyocar-
dial function on TTE during dobutamine infusion
(Figure 3).
Because myocardial function and blood flow did not re-
turn to normal in the LAD territory relative to the remote
territory at high work load, we assessed the tissue for evi-
dence of infarction or microvascular alterations. Triphenyl
tetrazolium chloride stain confirmed the viability of the re-
vascularized hibernating myocardium in all animals. To as-
sess for fibrosis or abnormal vascularity, Masson trichromeending coronary artery (LAD) stenosis (white arrows) before revasculariza-
l stenosis of left anterior descending coronary artery (LAD, thin arrow)with
rtery anastomosis (thick arrow) at 4 weeks after revascularization (CABG).
ery c January 2011
FIGURE 3. Fluorescently labeled colormicrospheres demonstrated return
of blood flow in revascularizedmyocardium to baseline flow at rest but with
significant reduction remaining during dobutamine infusion at 40 mg/(kg $
min) for 5minutes (n¼ 7) in left anterior descending coronary artery (LAD)
territory relative to remote territory. Asterisk indicates P<.05.
Kelly et al Evolving Technology/Basic Sciencestain of the remote myocardium was compared with that in
the revascularized hibernating LAD territory. We did not
find significant fibrosis or alteration in microvascular archi-
tecture (Figure 4).
Because of the reduced function and blood flow with do-
butamine infusion despite revascularization and the absence
of scar, we analyzed mitochondrial oxygen consumption
and proteomic expression as potential mechanisms of im-
paired oxygen use. We found that the RCI in the revascular-
ized LAD region was lower than that in the remote region
(Table 1). We compared this finding with the RCI from
hibernating myocardium12 and found that the RCI was
improved in the revascularized LAD myocardium relative
to hibernating LAD myocardium.
By using iTRAQ analysis to identify and quantify the al-
terations in the ETC mitochondrial proteins, we found con-
sistent reductions in expression of the mitochondrial
oxidative phosphorylation protein subunits in complexes
I, II, III, IV, and V (Table 2) in the revascularized hibernat-
ing myocardium relative to normal swine myocardium.FIGURE 4. Revascularized left anterior descending coronary artery (LAD) hib
(B) stained with Masson trichrome stain (original magnification 320).
The Journal of Thoracic and CaDISCUSSION
The principal findings of our study are that successful
coronary artery revascularization of hibernating myocar-
dium in a well-characterized swine model of chronic myo-
cardial ischemia does not normalize maximal oxygen
consumption despite successful grafting with LITA conduit.
Basal contractile function and blood flow improved after re-
vascularization, but not to a normal state with dobutamine
stress. Basal contraction may relate to persistent changes
within the mitochondrial inner membrane. Both key ETC
proteins and RCI were reduced, suggesting that there is
a persistent downregulation of the myocardial contractile
capacity that limits oxygen consumption with expenditure.
Similarly, we have shown that myocardial tissue adapts fa-
vorably to repetitive supply–demand challenges by reduc-
ing sources of oxidant stress, but ultimately at the expense
of maximal oxygen consumption and expenditure.11
The importance of mitochondrial function to cardiopro-
tection has been demonstrated by several observations. Iso-
lated mitochondria from preconditioned myocardium retain
the capacity to generate adenosine triphosphate after sus-
tained ischemia and reperfusion16 and are resistant to in vi-
tro anoxia and reoxygenation injury.17-19 In investigations
of hibernating myocardium, Page and associates20 have
demonstrated that myocardial hibernation is associated
with reductions in key mitochondrial proteins associated
with the ETC. With a proteomic method of total cellular
proteins, the importance of the decreased protein expression
was evident, with reduced enzymatic activity measurements
of key mitochondrial proteins, such as pyruvate dehydroge-
nase and cytochrome c oxidase. The reductions in mito-
chondrial ETC proteins and contractile function 5 months
after placement of a similar coronary artery constrictor sug-
gest that the decreased expression of ETC proteins is related
to the reduced blood flow. Whereas reductions in adenosine
triphosphate synthase also correlate with the reduction in
subendocardial blood flows in the hibernating myocardium,
at the same time overexpression of several cytosolic pro-
teins has been observed, including the antioxidant enzymeernating myocardial tissue (A) and revascularized remote myocardial tissue





TABLE 1. Respiratory Control Index of the revascularized left
anterior descending coronary artery region and the control remote
region in chronic hibernating (nonrevascularized) animals12 (n ¼ 10)
and revascularized animals (n ¼ 5)
LAD Remote P value*
Chronic hibernating swine 2.75  0.15 3.70  0.05 <0.005
Revascularized swine 3.87  0.33 4.66  0.30 0.035
LAD, Left anterior descending coronary artery. *By t test.
TABLE 2. Isobaric tags for relative and absolute quantification results
of hibernating mitochondria following revascularization compared to
normal myocardium (n ¼ 7)
Protein type and name
Revascularized
vs control P value
Oxidative phosphorylation
Complex I
NADH dehydrogenase 0.58  0.056 .0003
NADH dehydrogenase (ubiquinone) 1a 0.66  0.040 .0001
NADH dehydrogenase (ubiquinone) 1b 0.66  0.073 .0036
Complex II
Succinate dehydrogenase subunit A 0.71  0.080 .0117
Complex III
Ubiquinol–cytochrome c reductase 0.78  0.080 .0356
Ubiquinol–cytochrome c reductase,
Rieske polypeptide 1
0.65  0.035 <.0001
Complex IV
Cytochrome c oxidase subunit 6B 0.57  0.063 .0005
Cytochrome c oxidase subunit Vb 0.68  0.068 .0031
Cytochrome c oxidase subunit VIc 0.69  0.050 .0008
Complex V
ATP synthase F0 0.59  0.044 <.0001
ATP synthase, Hþ transporting,
mitochondrial F1 complex, a
0.66  0.079 .0047
ATP synthase, Hþ transporting,
mitochondrial F1 complex, b
0.66  0.053 .0007
ATP synthase, Hþ transporting,
mitochondrial F1 complex, d
0.53  0.071 .0006
ATP synthase, Hþ transporting,
mitochondrial F1 complex, g
0.74  0.055 .0028
NADH, Nicotinamide adenine dinucleotide (reduced form); ATP, adenosine triphos-
phate.




Ssuperoxide dismutase 1. Interestingly, the temporal increase
in the antioxidant proteins coincides with the time that ap-
optosis is diminished in their model.21 A logical hypothesis
is that superoxide production stimulates a stress response,
which reduces subsequent reactive oxygen species produc-
tion and thus promotes a survival pathway within the
mitochondria.22 Such mitochondrial adaptations preserve
viability in hibernating myocardium at the expense of en-
ergy production, and it is unknown to what extent these
changes are reversible with revascularization.
Accordingly, we sought a suitable model of hibernation
in swine to test whether successful revascularization could
reverse the mitochondrial alteration to key ETC proteins.
Somewhat surprisingly, despite restoration of baseline
blood flow and viable myocardium, mitochondrial ETC
protein expression remained depressed. The degree of alter-
ation may negatively affect myocardial functional recovery,
especially during increased workload. We found with a do-
butamine infusion that although the blood flow did increase
in the revascularized region, the maximal blood flow
increase was 30% less than that in the remote region. Al-
though we only evaluated recovery at 4 weeks after revascu-
larization, and clinical experience suggests that recovery
from hibernation may continue for several months after re-
vascularization, these results are intriguing and support
clinical observations that complete recovery of hibernating
myocardium is not guaranteed, despite successful revascu-
larization.
The novelty of this study is that it is the first report, to our
knowledge, of bypass grafting to a coronary artery in a suit-
able animal model of myocardial hibernation. Our large an-
imal model mimics the clinical scenario of surgical
revascularization of hibernating myocardium and therefore
is relevant to patient care. Several longitudinal studies of
patients with ischemic cardiomyopathy have demonstrated
that progressive heart failure may persist despite successful
revascularization.23-25 These clinical studies have not
provided a unifying concept to predict when the decrease
in contractile function in chronic, persistent myocardial
ischemia may ultimately recover.
We have demonstrated for the first time in a large animal
model that an aggressive intervention that restores blood
flow to the hibernating myocardium is feasible and allows
simultaneous mitochondrial proteomic analysis and
myocardial assessment. We found in a swine model of266 The Journal of Thoracic and Cardiovascular Surgmyocardial hibernation in which regional blood flow and
contraction were reduced in the absence of necrosis that suc-
cessful bypass with LITA graft to the involved LAD artery
improves but does not normalize regional function. The in-
ability to recruit maximal blood flow at high work states and
the reduced expression of key ETC proteins within involved
mitochondria together suggest that persistent mitochondrial
adaptations within hibernating myocardium may underlie
the mechanisms of persistent myocardial dysfunction in
successfully revascularized hibernating heart tissue. Future
studies should address whether restoration of mitochondrial
protein expression, either pharmacologically or with
cell-based therapies, might modify the persistent contractile
abnormalities within chronically ischemic heart tissue.
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Dr Keith Horvath (Bethesda, Md). Thank you, Dr Kelly,
excellent presentation of some very intriguing work. I have just
a few questions.The Journal of Thoracic and CaThe results that you show document that there is some persistent
dysfunction particularly at the mitochondrial level after revascu-
larization. Are you convinced that this is because of that at the cel-
lular level or is it possible that there still is a blood flow problem?
You’ve documented that the baseline resting blood flow returns to
normal but with dobutamine stress there is a difference. Again, is it
a result of the flow in or is it as a result of the mitochondrial dys-
function?
From a mechanistic point of view, what do you postulate is
causing this? One of the main reasons may be apoptosis, and do
you have any data that supports that as the principal mechanism?
And then, finally, from a clinical implication point of view, is
there something that we should be doing in the operating room
or postoperatively to prevent this from happening? And then to
delve somewhat into a controversial area, is this because these
were performed off-pump instead of on-pump?
Dr Kelly. Thank you for your questions.
To begin with, we did consider other reasons for decreased per-
fusion. We looked at the vascular reactivity in the resistant vessels
of the myocardium and what we found is that the contractility re-
mained normal in the LAD versus circumflex vessels. What we
have not yet investigated, and our future studies are designed to
study, is the ability of the LAD vessels to relax normally. I think
when we perform a dobutamine stress test, what may be happening
is a signaling for dilation towhich thevasculature in the hibernating
tissue is unable to respond. That will be for future considerations.
When we looked at possible mechanisms as to why the myocar-
dial function remains abnormal, we did not look specifically for
apoptosis within the tissue. But looking at the histology and the
electron microscopy, we have found that these cells and mitochon-
drial remain normal in appearance and have not noticed a signifi-
cant presence of necrosis or fibrosis.
As the cellular and tissue structure remained intact following
chronic ischemia and revascularization, we investigated other pos-
sible mechanisms by which the cells fail to recover upon revascu-
larization and focused on oxygen utilization in the mitochondria.
With uncoupling of oxidative phosphorylation, the mitochondria
are unable to maximally respond to the oxygen delivered and
ATP production remains impaired. When we looked at the mito-
chondrial function using Clark’s electrode, the respiratory control
index in hibernating tissue remained depressed. When we looked
at our revascularized hibernating tissue compared to remote, it re-
mained depressed as well. This finding suggests that the mitochon-
dria themselves remain dysfunctional compared to normal tissue.
And finally, I agree with you, the off-pump technique could
clearly impact the microthrombus occurring in these animal
models. In particular for this model, pigs can be very thrombo-
genic. However, for technical support and recovery reasons, it
was better to do the procedure off-pump and we did not see any
evidence of thrombus intraoperatively or evidence of infarction
at the time of the terminal study. Also, we aggressively heparinized
the animals to prevent thrombosis
Dr Paul Kurlansky (Miami, Fla). Beautiful piece of work, it
was very intriguing. I had 3 questions.
One was, clearly you seem to be postulating that there is some
sort of trigger which is set off in the hibernatingmyocardiumwhich
is not readily reversed. Do you have any idea specifically what this
trigger is mechanistically and how we therefore might address it?rdiovascular Surgery c Volume 141, Number 1 267




SSecondly, another approach might be whether or not you had
looked at the effect of a preconditioning, preconditioner, even
postconditioning, and if it somehow affects the ability of revascu-
larization to turn this trigger the other direction.
And the third question is, it’s very difficult to do the experiments
you’re doing and it’s even more difficult to do them for prolonged
survival; however, over time, do you have any idea if after several
months does the trigger get reversed with adequate revasculariza-
tion?
Dr Kelly.We don’t know what the trigger for hibernation is but
agree that there is some alteration that occurs in the mitochondria
that moves it into survival mode rather than necrosis or apoptosis.
It is possibly an upregulation of uncoupling protein but the trigger
for this response is unclear. Discovering that trigger, and the mech-
anism for reversal, is an important part of our investigations going
forward.268 The Journal of Thoracic and Cardiovascular SurgWehave looked at the spectrum of preconditioning in relation to
hibernation, but not yet in the revascularization model. However, if
you look at what we’ve created, we seem to have transitioned from
hibernation to stunned myocardium, where you have normal blood
flow yet depressed function. If we continue on that spectrum, we
may indeed see that finally at a year the myocardial function would
return to normal.
We plan to allow for more prolonged recovery in this animal
model to study the recovery of the myocardium over time. This
will mimic the clinical experience of continued recovery over sev-
eral months. For me, as a clinician, the question would be: How
can I help that recovery occur more quickly following revascular-
ization? We are looking at manipulating possible triggers using
pharmacologic adjuvant therapy as well as using stem cells to per-
mit more rapid recovery. Those are our speculations for the future
directions using this model.ery c January 2011
